Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636064 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,671
- Enrollment target
NCT00636064: Completed Phase 3 study, sponsored by Pfizer.
NCT00636064 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 1,671 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (116% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636064, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,671 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of parecoxib/valdecoxib therapy and placebo/valdecoxib therapy for the treatment of pain after coronary artery bypass surgery
Interventions
- DRUG Parecoxib Sodium/Valdecoxib
- DRUG Placebo/Valdecoxib
- OTHER Placebo/Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,671 participants |
| Start Date | 2003-01 |
| Est. Completion | 2004-01 |
| Phase | Phase 3 |
What the finished NCT00636064 record still lists
NCT00636064 is an interventional study that assigns participants to a tested intervention. Its 1,671 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (116% higher).
The record links to 0 conditions, and to 3 interventions - of which Parecoxib Sodium/Valdecoxib is the first listed.
NCT00636064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00636064 about?
NCT00636064 is a clinical study titled "A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery". The purpose of this study is to evaluate the efficacy and safety of parecoxib/valdecoxib therapy and placebo/valdecoxib therapy for the treatment of pain after coronary artery bypass surgery
What is the current status of trial NCT00636064?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,671 participants. The study started on 2003-01. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00636064?
The interventions under investigation include: Parecoxib Sodium/Valdecoxib (DRUG), Placebo/Valdecoxib (DRUG), Placebo/Placebo (OTHER).
Who is sponsoring clinical trial NCT00636064?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00636064's enrollment target sits among peer trials
1,671 136th of 2000 higher than 1,865 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia